Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Operations: 2020-2025

Historic Cash from Operations for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$15.2 million.

  • Maravai Lifesciences Holdings' Cash from Operations fell 215.33% to -$15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.4 million, marking a year-over-year decrease of 265.40%. This contributed to the annual value of $7.5 million for FY2024, which is 94.09% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Cash from Operations stood at -$15.2 million for Q3 2025, which was down 47.59% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Cash from Operations registered a high of $165.9 million during Q2 2021, and its lowest value of -$15.2 million during Q3 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Cash from Operations averaged around $9.0 million, with its median value being $7.8 million (2023).
  • In the last 5 years, Maravai Lifesciences Holdings' Cash from Operations soared by 1,328.66% in 2021 and then plummeted by 287.91% in 2024.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Cash from Operations stood at $58.7 million in 2021, then soared by 69.10% to $99.3 million in 2022, then crashed by 92.16% to $7.8 million in 2023, then plummeted by 287.91% to -$14.6 million in 2024, then plummeted by 215.33% to -$15.2 million in 2025.
  • Its last three reported values are -$15.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$9.4 million during Q1 2025.